By The Pepi Girl · Last updated October 8, 2026
Appetite, blood sugar, energy, and weight can all behave differently as you age. This is the most searched peptide topic, and the one where the rules matter most.
What people are asking about
GLP-1 medications like semaglutide and tirzepatide (the active ingredients behind Ozempic, Wegovy, Mounjaro, and Zepbound) are peptides. You will also hear about retatrutide, MOTS-c, and HCG.
What the evidence shows
Semaglutide and tirzepatide have gone through large clinical trials and are FDA-approved under specific brand names for diabetes and weight management. Retatrutide is still investigational and in clinical trials. MOTS-c is in early research. HCG has FDA-approved uses in fertility treatment, and its use in weight-loss protocols is off-label.
Where the rules stand
This is the clearest example of why the three lanes matter. The approved medications come with dosing standards, manufacturing oversight, and a prescriber who monitors you. Compounded versions are in a more complicated regulatory space, and products sold online as “research only” carry the most uncertainty about what is actually in the vial.
Semaglutide
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely known for supporting appetite regulation and weight loss. It works by slowing digestion and signaling fullness to the brain. FDA-approved under specific brand names for diabetes and weight management; compounded versions exist in a more complicated regulatory space.
Tirzepatide
A dual GLP-1/GIP receptor agonist, one step further than semaglutide in its mechanism, also associated with appetite control and metabolic support. Like semaglutide, it has FDA-approved branded versions, with compounded versions subject to separate rules.
Retatrutide
An investigational “triple agonist” (GLP-1, GIP, and glucagon receptors) still in clinical trials. It’s discussed for its potential metabolic and weight-management effects.
MOTS-c
A mitochondrial-derived peptide studied for its role in cellular energy metabolism, with early research interest around metabolic health and exercise capacity. Research is still in relatively early stages.
SS-31 (Elamipretide)
A mitochondria-targeted peptide being studied in clinical trials for conditions involving mitochondrial dysfunction, including certain heart and muscle conditions.
Tesamorelin
A GHRH analog with an FDA-approved branded use for a specific type of fat redistribution in HIV patients; discussed more broadly for its effects on visceral fat and growth hormone support, though that broader use is off-label.
HCG (Human Chorionic Gonadotropin)
A hormone (again, distinct from the synthetic research peptides above) with established FDA-approved medical uses in fertility treatment; it has also been used off-label in some weight-loss protocols.
Everyday basics that still matter
Protein, strength training, sleep, and fiber support any metabolic plan and help protect muscle during weight loss.
Where to go next
- New to peptides? Start with Peptide Basics.
- Wondering how to vet a source? Read Safe Sourcing.
Frequently asked questions
Are semaglutide and tirzepatide peptides?
Yes. They are GLP-1-based peptide medicines, FDA-approved under specific brand names for diabetes and weight management.
Is retatrutide approved?
No. Retatrutide is investigational and still in clinical trials.
For general education only. This is not medical advice, and nothing here is a treatment recommendation. Regulatory details are current as of 2026 and can change. Talk to a licensed clinician before starting, stopping, or changing anything.